Armando Anido
2015
In 2015, Armando Anido earned a total compensation of $4.7M as Chairman of the Board and Chief Executive Officer at Zynerba Pharmaceuticals, a 361% increase compared to previous year.
Compensation breakdown
| Bonus | $324,450 |
|---|---|
| Salary | $515,000 |
| Stock Awards | $3,793,947 |
| Other | $27,636 |
| Total | $4,661,033 |
Anido received $3.8M in stock awards, accounting for 81% of the total pay in 2015.
Anido also received $324.5K in bonus, $515K in salary and $27.6K in other compensation.
Rankings
In 2015, Armando Anido's compensation ranked 1,768th out of 13,638 executives tracked by ExecPay. In other words, Anido earned more than 87.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,768 out of 13,638 | 87th |
Division Manufacturing | 640 out of 5,190 | 88th |
Major group Chemicals And Allied Products | 237 out of 1,854 | 87th |
Industry group Drugs | 183 out of 1,528 | 88th |
Industry Pharmaceutical Preparations | 147 out of 1,182 | 88th |
Source: SEC filing on April 13, 2016.
Anido's colleagues
We found three more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2015.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019